CAS: 147523-65-7 - (4S,5R)-N-(4-bromophenyl)-3-oxo-4,5-diphenylpyrazolidine-1-carboxamide
Formula:C22H18BrN3O2
InChI:InChI=1/C22H18BrN3O2/c23-17-11-13-18(14-12-17)24-22(28)26-20(16-9-5-2-6-10-16)19(21(27)25-26)15-7-3-1-4-8-15/h1-14,19-20H,(H,24,28)(H,25,27)/t19-,20-/m0/s1
- Synonyms:
- 1-Pyrazolidinecarboxamide, N-(4-bromophenyl)-3-oxo-4,5-diphenyl-, (4S,5R)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
LY 288513 REF: 3D-XFA52365CAS: 147523-65-7 | Min. 95% | To inquire | Fri 24 Jan 25 | |
LY288513 REF: TM-T22949CAS: 147523-65-7 | 98% | 907.00 €~4,031.00 € | Fri 31 Jan 25 | |
LY 288513 REF: TR-L503168CAS: 147523-65-7 | - - - | - - - | Discontinued product |
LY 288513
CAS:147523-65-7
LY 288513 is a novel, potent, and selective 5-HT1A receptor agonist. It was designed to …
Formula:
C22H18BrN3O2
Purity:
Min. 95%
Molecular weight:
436.3 g/mol
Ref: 3D-XFA52365
1mg | 194.00 € | ||
2mg | 325.00 € | ||
5mg | 550.00 € | ||
10mg | 863.00 € | ||
25mg | 1,623.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
LY288513
CAS:147523-65-7
Selective CCK2 receptor antagonist
Formula:
C22H18BrN3O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
436.3
Ref: TM-T22949
10mg | 936.00 € | ||
50mg | 4,031.00 € |
Estimated delivery in United States, on Friday 31 Jan 2025
LY 288513
CAS:147523-65-7
Applications LY 288513 is a CCK-B antagonist, which blocks the effects of nicotine withdrawal on …
Formula:
C22H18BrN3O2
Color and Shape:
White Solid
Molecular weight:
436.30
Ref: TR-L503168
1mg | Discontinued | Request information |